North America Respiratory Care Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

 Respiratory Care Devices Market Size

• The North America Respiratory Care Devices market size was valued at USD 8.96 billion in 2024 and is expected to reach USD 33.19 billion by 2032, at a CAGR of 12.78% during the forecast period of 2025-2034.
• The market growth is primarily driven by the rising prevalence of respiratory diseases such as COPD and asthma, coupled with an aging population susceptible to respiratory illnesses.
• Furthermore, technological advancements in respiratory care devices, including portable and homecare ventilators, and increasing awareness regarding early disease management, are fueling market expansion. The growing demand for sleep apnea treatment devices also significantly contributes to market growth.

Respiratory Care Devices Market Analysis

• The increasing prevalence of chronic respiratory diseases and the rising geriatric population are significant drivers for the Respiratory Care Devices market.
• Technological advancements in respiratory support systems, diagnostic equipment, and therapeutic devices are expanding their applicability and driving market growth by offering more effective and patient-friendly solutions.

• U.S. dominates the Respiratory Care Devices market with the largest revenue share of 41.80% in 2025, due to a high prevalence of respiratory diseases, advanced healthcare infrastructure, and substantial healthcare expenditure facilitating the adoption of sophisticated devices.
• The Therapeutic Devices segment is expected to dominate the Respiratory Care Devices market with a market share of 39.2% in 2025, due to the increasing need for ventilators, oxygen concentrators, and nebulizers in treating a growing patient population with chronic and acute respiratory conditions.

Report Scope and Respiratory Care Devices Market Segmentation    

Respiratory Care Devices Market Trends

“Rising Prevalence of Chronic Respiratory Diseases”

• COPD, often triggered by prolonged exposure to irritants like smoking and air pollution, leads to irreversible lung damage, affecting millions and significantly increasing the need for respiratory care devices.
• The rising prevalence, particularly in aging populations and regions with high levels of air contamination, necessitates advanced diagnostic and therapeutic interventions.

• For Instance, according to the Lung Association, long-term exposure to air pollution, a significant contributor to chronic respiratory diseases, can lead to the development of conditions like COPD and asthma. Fine particulate matter, a key component of air pollution, can penetrate deep into the lungs, causing inflammation and increasing the risk of respiratory infections and aggravated asthma, highlighting the direct link between environmental factors and the rising prevalence of these diseases.

• This inflammatory condition of the airways, with increasing prevalence linked to environmental factors and genetics, causes recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, driving demand for a range of respiratory devices.
• The growing incidence, especially among children and in urbanized areas with elevated allergen and pollution levels, underscores the critical need for effective management tools.

Respiratory Care Devices Market Dynamics

Driver

“Aging population needs breathing support.”

• The aging population is a significant driver in the Respiratory Care Devices market. The higher susceptibility of older adults to respiratory illnesses like pneumonia and COPD, coupled with a greater prevalence of sleep apnea, fuels the demand for devices such as ventilators, oxygen concentrators, and CPAP machines across the region.
• Elderly individuals often experience a natural decline in lung function and respiratory muscle strength, making them more vulnerable to conditions like pneumonia and increasing their reliance on respiratory support systems.
• The rising prevalence of these age-related physiological changes necessitates a greater need for therapeutic and assistive breathing devices.

• For Instance, the aging population in the U.S. faces a higher risk of respiratory illnesses and declining lung function, driving increased demand for respiratory care devices. Conditions like COPD and sleep apnea are more prevalent in older adults, necessitating interventions such as oxygen therapy, CPAP machines, and ventilators to maintain quality of life and manage respiratory distress within this demographic.

• With longer life expectancies, the duration of managing chronic respiratory conditions in older adults also increases, further driving the demand for long-term respiratory care devices and home healthcare solutions. This extended need for support underscores the importance of accessible and effective respiratory technologies for the aging population.

Restraint/Challenge

“High Cost of Advanced Respiratory Care Technologies”

• The sophisticated technology and features incorporated into advanced respiratory care devices, such as high-end ventilators and complex diagnostic systems, often result in substantial upfront and maintenance costs.
• This can create a barrier to adoption, particularly in developing economies and for smaller healthcare facilities with budget constraints.

• For Instance, Advanced respiratory technologies, like high-end ventilators and complex diagnostics, demand significant upfront investment and continuous maintenance expenses. This high cost can restrict their widespread adoption, particularly in developing nations and smaller healthcare centers with limited financial resources.

• The high cost of advanced respiratory technology hinders widespread adoption, especially in resource-limited settings, creating disparities in access to crucial life-saving equipment and sophisticated diagnostics.

Respiratory Care Devices Market Scope

The market is segmented on the basis product, indication and end user.

By Product

On the basis of Product, the North America Respiratory Care Devices market is segmented into Therapeutic Devices, Monitoring Devices, Diagnostic Devices and Consumables & Accessories. The Therapeutic Devices segment dominates the largest market revenue share of 54.67% in 2025, due to the widespread use of ventilators, oxygen therapy devices, and nebulizers in treating a significant patient population with chronic and acute respiratory conditions.

The Monitoring Devices segment is anticipated to witness the fastest growth rate of 34.82% from 2025 to 2032 owing to the increasing adoption of continuous respiratory monitoring in hospitals and home care settings, coupled with advancements in sensor technology and data analytics.

By Indication

On the basis of Indication, the North America Respiratory Care Devices market is segmented into Chronic Obstructive Pulmonary Disease (COPD), Sleep Apnea, Asthma, Infectious Diseases and Other Indications. The Chronic Obstructive Pulmonary Disease (COPD) segment dominates the largest market revenue share of 41.38% in 2025, due to the high prevalence of COPD in the aging North American population and the increasing demand for devices that aid in managing this chronic respiratory illness.

The Sleep Apnea segment is anticipated to witness the fastest growth rate of 33.89% from 2025 to 2032 fueled by growing awareness of sleep apnea, increasing diagnosis rates, and the rising adoption of CPAP and BiPAP devices for effective management.

By End User

On the basis of Indication, the North America Respiratory Care Devices market is segmented into Hospitals, Home Care Settings and Ambulatory Care Centers. The Hospitals segment dominates the largest market revenue share of 37.79 % in 2025, due to the high volume of critical respiratory care procedures and the concentration of advanced respiratory support systems in hospital settings.

The Home Care Settings segment is anticipated to witness the fastest growth rate of 29.89% from 2025 to 2032 driven by the increasing preference for home-based respiratory care, advancements in portable and user-friendly devices, and the growing need for cost-effective and convenient long-term respiratory management.

Respiratory Care Devices Market Regional Analysis

• U.S. dominates the Respiratory Care Devices market with the largest revenue share of 42.80% in 2024, driven by a increasing industrialization, growing environmental concerns, and rising demand for advanced analytical techniques in rapidly developing economies ,which are significantly investing in research and manufacturing sectors.
• This growth is further supported by increasing government emphasis on stringent environmental monitoring and the escalating demand for sophisticated analytical solutions across diverse industries within these rapidly developing economies.

U.S. Respiratory Care Devices Market Insight

The U.S. Respiratory Care Devices market captured the largest revenue share of 56.71% within North America in 2025, driven by a increasing industrialization, growing environmental concerns, and rising demand for advanced analytical techniques in rapidly developing economies which are significantly investing in research and manufacturing sectors.

Canada Respiratory Care Devices Market Insight

The Canada Respiratory Care Devices market captured the largest revenue share of 46.71% within North America in 2025, due to the presence of a well-established healthcare infrastructure, high healthcare expenditure, and a large patient population with respiratory disorders.

Mexico Respiratory Care Devices Market Insight

The Mexico Respiratory Care Devices market captured the largest revenue share of 38.71% within North America in 2025, due to increasing government initiatives to improve healthcare access, a rising prevalence of respiratory diseases, and a growing adoption of advanced respiratory care technologies.

Respiratory Care Devices Market Share

The Respiratory Care Devices industry is primarily led by well-established companies, including:

• DeVilbiss Healthcare LLC (U.S.)
• Drägerwerk AG & Co. KGaA (Germany)
• Fisher & Paykel Healthcare Limited (New Zealand)
• GENERAL ELECTRIC (U.S.)
• Medtronic (Ireland)
• Koninklijke Philips N.V. (Netherlands)
• GlaxoSmithKline plc (U.K.)
• ResMed (U.S.)
• BD (U.S.)
• Hamilton Medical (Switzerland)
• Masimo (U.S.)
• Air Liquide (France)
• VYAIRE (U.S.)
• Getinge AB (Sweden)
• Abbott (U.S.)
• 3M (U.S.)
• AstraZeneca (U.K.)
• MicroAire Surgical Instruments LLC. (U.S.)
• Smith & Nephew Inc. (U.K.)
• Hill-Rom Services Inc. (U.S.)
• Breathe Technologies, Inc. (U.S.)

Latest Developments in North America Respiratory Care Devices Market

• In June 2024, GlaxoSmithKline plc partnered with a leading digital health company to integrate smart sensor technology into their Ellipta® inhaler. This collaboration aims to provide patients with real-time feedback on their inhalation technique and medication adherence via a connected mobile application, potentially improving treatment outcomes for asthma and COPD.
• In September 2024, GSK announced the launch of a new digital support program designed to complement their inhaled corticosteroids. This program offers personalized reminders, educational resources, and guidance on proper inhaler use, accessible through a dedicated mobile app, aiming to enhance patient self-management and adherence. 

SKU-1764